Pancreatic Cancer Research

ResearcherWuhan UniversityActive in the last 2 years

Zhi‐Gang Tang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5390-9670; OpenAlex author ID A5077428837. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
20
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 5 papers · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper

Papers 11

  1. Identification of m6A modification patterns and RBM15 mediated macrophage phagocytosis in pancreatic cancer: An integrative analysis. Last author DOI 10.1016/j.bbadis.2024.167304↗
  2. CASC9 potentiates gemcitabine resistance in pancreatic cancer by reciprocally activating NRF2 and the NF-κB signaling pathway. Co-author DOI 10.1007/s10565-022-09746-w↗
  3. Tumorigenic and immunological roles of Heat shock protein A2 in pancreatic cancer: a bioinformatics analysis. Last author DOI 10.1590/1806-9282.20210495↗
  4. Long non‑coding RNA 01614 hyperactivates WNT/β‑catenin signaling to promote pancreatic cancer progression by suppressing GSK‑3β. Last author DOI 10.3892/ijo.2022.5406↗
  5. Letter re: Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancreatic… Last author DOI 10.1016/j.ejca.2021.09.006↗
  6. Upregulated HSPA2 predicts early relapse of pancreatic cancer after surgery. Co-author DOI 10.21037/gs-21-262↗
  7. The reciprocal loop of MALAT1 and HIF-1α facilitates gemcitabine resistance in pancreatic cancer by enhancing glycolysis Co-author DOI 10.21203/rs.3.rs-135235/v2↗
  8. Panax notoginseng Saponins Promote Cell Death and Chemosensitivity in Pancreatic Cancer through the Apoptosis and Autophagy Pathways. Last author DOI 10.2174/1871520620999201110191459↗
  9. Hypoxia-induced lncRNA CASC9 enhances glycolysis and the epithelial-mesenchymal transition of pancreatic cancer by a positive feedback loop with AKT/HIF-1α sig… Co-author PMID 33520364↗
  10. Circulating exosomal microRNAs as novel potential detection biomarkers in pancreatic cancer. Last author DOI 10.3892/ol.2020.11691↗
  11. Hypoxia potentiates gemcitabine-induced stemness in pancreatic cancer cells through AKT/Notch1 signaling. Co-author DOI 10.1186/s13046-018-0972-3↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lulu Zhai · 5 shared papers, 2021–2022 · strength 0.89
  2. Tong-Fa Ju · 3 shared papers, 2021–2022 · strength 0.56
  3. Zhengle Zhang · 4 shared papers, 2018–2023 · strength 0.55
  4. Lun Wu · 3 shared papers, 2020–2022 · strength 0.42
  5. Jing Tao · 3 shared papers, 2018–2023 · strength 0.41
  6. Lichao Yao · 2 shared papers, 2021–2024 · strength 0.36
  7. Hanjun Li · 2 shared papers, 2021–2023 · strength 0.32
  8. Pei Mei · 2 shared papers, 2021 · strength 0.26
  9. Lin Ye · 2 shared papers, 2020–2021 · strength 0.25
  10. Kaihuan Yu · 1 shared paper, 2024 · strength 0.21
  11. Yuefeng Zhang · 1 shared paper, 2024 · strength 0.21
  12. Cong Lu · 1 shared paper, 2024 · strength 0.21
  13. Wei Wang · 1 shared paper, 2024 · strength 0.21
  14. Longjiang Chen · 1 shared paper, 2023 · strength 0.20
  15. Long-Jiang Chen · 1 shared paper, 2022 · strength 0.17
  16. Hengqiang Zhao · 1 shared paper, 2021 · strength 0.14
  17. Jing Tao · 1 shared paper, 2021 · strength 0.14
  18. Hehe Li · 1 shared paper, 2021 · strength 0.12
  19. Hongmei Wang · 1 shared paper, 2020 · strength 0.10
  20. Kongfan Zhu · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.